JAZZ
$109.54
Revenue | $1011.94Mn |
Net Profits | $94.15Mn |
Net Profit Margins | 9.3% |
PE Ratio | 22.52 |
Jazz Pharmaceuticals Plc’s revenue jumped 13.34% since last year same period to $1011.94Mn in the Q1 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 0% jump in its revenue since last 3-months.
Jazz Pharmaceuticals Plc’s net profit jumped 35.63% since last year same period to $94.15Mn in the Q1 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 0% jump in its net profits since last 3-months.
Jazz Pharmaceuticals Plc’s net profit margin jumped 19.66% since last year same period to 9.3% in the Q1 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 0% jump in its net profit margins since last 3-months.
Jazz Pharmaceuticals Plc’s price-to-earnings ratio after this Q1 2024 earnings stands at 22.52.
EPS Estimate Current Quarter | 4.8 |
EPS Estimate Current Year | 4.8 |
Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 4.8 - a 14.83% jump from last quarter’s estimates.
Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 4.8.
Earning Per Share (EPS) | 2.68 |
Return on Assets (ROA) | 0.04 |
Return on Equity (ROE) | 0.09 |
Jazz Pharmaceuticals Plc’s earning per share (EPS) fell -32.15% since last year same period to 2.68 in the Q1 2024. This indicates that the Jazz Pharmaceuticals Plc has generated -32.15% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Jazz Pharmaceuticals Plc’s return on assets (ROA) stands at 0.04.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Jazz Pharmaceuticals Plc’s return on equity (ROE) stands at 0.09.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-26 | 4.18 | 2.68 | -35.89% |